BISvsUJB
ProShares UltraShort Nasdaq Biotechnology against ProShares Ultra High Yield — the fee, the flows, the book, and a year head-to-head.
Head to head
| BIS | UJB | |
|---|---|---|
| Expense ratio | 0.95% | 0.96% |
| Assets | $1939.87T | $5901.50T |
| Net flow, 1 month | — | −$4M |
| Net flow, 1 year | +$2K | +$2M |
| Return, YTD | -38.2% | -6.7% |
| Return, 1 year | -51.6% | -5.8% |
| Avg daily volume | 8K | 14K |
| Holdings | 7 | 5 |
| Listed | Apr 9, 2010 | Apr 14, 2011 |
| Options market | Yes | No |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS